STOCK TITAN
  1. Home
  2. MGEN

MGEN Stock Price, News & Analysis

MGEN

Company Description

MGEN (Nasdaq: MGEN) is a publicly traded company.

MGEN stock has gained 3692.7% over the past year.

This page provides a comprehensive overview of MGEN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+3692.65%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

MGEN (MGEN) stock. Over the past 12 months, the stock has gained 3692.7%.

Latest News

View All
-0.09%

miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team

management
+6.88%

miRagen Enters into License Agreement with Xencor for use of Xtend™ Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease

0.00%

miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates

earnings
+142.35%

miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.

acquisition
-23.49%

miRagen Announces Internal Review of Preliminary Topline Data for the Phase 2 SOLAR Clinical Trial of Cobomarsen in Patients with Cutaneous T-Cell Lymphoma (CTCL)

clinical trial
-12.77%

miRagen Announces Leadership Transition and Review of Strategic Alternatives 

management

MGEN has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include management, earnings, acquisition, clinical trial, fda approval. View all MGEN news →

SEC Filings

View All

No SEC filings available for MGEN.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months